Refine by:
-
Letter to Members of Congress on Research and Innovation
Letter to Members of Congress expressing support of H. RES. 361, which would name May 7th as National Brain Donation Awareness Day. -
Racism as a Risk Factor for Psychosis
The social determinants of health framework is commonly used to conceptualize the cultural and structural factors affecting mental health. A new review applies this framework specifically to psychosis-related health outcomes in communities of color, demonstrating that structural factors such as racial discrimination, food insecurity, and police violence are significant risk factors for psychosis within these communities. These findings inform a more nuanced understanding of the increased rates of psychosis and disparities in mental health treatment of Black and Latinx populations across the US – a critical step to developing policies and practice to address these issues. To learn more, read the article in Annual Review of Clinical Psychology. -
Regulatory Comment to SAMHSA on Research and Innovation and Mental Health Funding
NAMI’s comments on SAMHSA’s 2023–2026 Draft Strategic Plan, offering strong support for the agency’s five priority areas and recommendations on ways to further strengthen the Strategic Plan. -
Providers and Public Believe Mental Health Workforce Shortage Will Have Negative Impact
The mental health workforce is already experiencing a shortage, and by 2025, estimates suggest the U.S. will have 31,000 fewer practitioners than necessary to meet demand. A recent survey of 750 behavioral health workers and 2,000 U.S. adults conducted by the National Council for Mental Wellbeing found both groups are concerned that the shortage will negatively impact society. More than three quarters (76%) of behavioral health workers worry specifically about the potential loss of life due to workforce shortages. The report advocates for public policy changes to address provider concerns – such as increased caseload and burnout – to improve recruitment and retention of this critical workforce. To learn more, see the report from the National Council for Mental Wellbeing. -
Letter to Congressional Committee Leadership on Research and Innovation & Criminal Justice
Letter to House and Senate Appropriations Committee leadership requesting $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health and $1 million for the National Institute of Justice to conduct public health research into firearm morbidity and mortality prevention. -
Interpersonal Therapy for Depression During Pregnancy
Providing brief and recurrent interpersonal therapy may be an effective strategy in reducing depressive symptoms during pregnancy. A randomized clinical trial of 234 pregnant adults with elevated depression symptoms treated patients with either enhanced usual care (EUC) or MomCare. EUC consists of maternity support services with optional mental health counseling while MomCare is a culturally relevant intervention of weekly, interpersonal therapy sessions with psychoeducation. Overall, participants in the MomCare group showed a greater reduction in depressive scores compared to participants receiving EUC. Future research will focus on whether children born to individuals undergoing the MomCare intervention experience a reduction in risk for their own mental health concerns. To learn more, see the study in JAMA Psychiatry. -
Initial Research on TikTok’s Mental Health Impacts
Current research suggests social media overall may have positive and negative impacts on mental health. A novel study interviewed 16 participants about their experience interacting with mental health content on TikTok to learn about the platform’s specific impacts. The most commonly reported benefits were a sense of self-discovery and social support through a virtual community. While users noted that mental health information was easily accessible, they worried about its credibility. Researchers also warn that the algorithm-driven platform may continuously serve users unwanted or harmful content. Further research is needed to better understand how TikTok affects mental health, including how to maintain its benefits while mitigating drawbacks. To learn more, see the study here. -
Letter to FDA Commissioner & HHS Secretary on Research and Treatment Innovation
Letter to HHS Secretary Becerra and FDA Commissioner Califf urging the Federal Drug Administration FDA to reissue its ban of electrical stimulation devices used to treat self-injurious or aggressive behavior. -
Thriving on the Bipolar Spectrum: Changing the Narrative with Stories of Lived Experience
We’re now on a shared mission to end the stigma, maximize healing and save lives by spreading education and inspiration. -
FDA Approves Over-the-Counter Naloxone Spray
Naloxone, commonly known under the brand name Narcan, is a medication that rapidly reverses the effects of an opioid overdose. Until this year, all forms of naloxone had been designated as prescription-only. After hearing from an expert advisory panel, the U.S. Food and Drug Administration (FDA) approved the sale of over-the-counter naloxone hydrocholoride nasal spray nationwide in March. The decision removes a critical access barrier to the life-saving treatment, thereby reducing overdose deaths and the associated stigma. Implementation will be ongoing in the coming months with pending information on the cost of the medication. To learn more, see the news release from the FDA.
